Speaker

Meena B Bansal, MD, FAASLD

Icahn School of Medicine at Mount Sinai (ISMMS)
Meena B Bansal, MD, FAASLD

Biography

Dr. Bansal has been on faculty at Mount Sinai since 2001. In addition to maintaining an NIH funded research program focused on molecular mechanism of liver fibrosis with seminal contributions to our understanding of liver fibrosis in people living with HIV, Dr. Bansal held many different leadership roles at Mount Sinai, including Transplant Hepatology Fellowship Director, Director of Translational Research, Medical Director of Hospital-Based Clinics, Chief Medical Officer of Mount Sinai Care, LLC, Deputy Chief Medical Officer for Mount Sinai Health Partners, and Vice President of Population Health for Quality and Efficiency. In these latter roles, she helped generate increased quality dollars in value-based contracts, created Mount Sinai's first ambulatory pharmacy program and addressed broad population health needs. She has also served as the principal investigator for numerous clinical trials for MASH/NASH. At the international/national levels, she held the position of Secretary for the American Association for the Study of Liver and currently serves as the Director of the newly formed MASLD/MASH (NAFLD/NASH) Center of Excellence at Mount Sinai. In January 2024, Dr. Bansal was named System Chief, Division of Liver Diseases for the Mount Sinai Health System.

Sessions

8:00 AM - 1:00 PM
Convention Center - General Session, Hall A
Recorded session Ticketed event

Postgraduate Course, Parts 1–4: Advancing Hepatology—Breakthroughs Shaping Tomorrow's Care (Ticketed)

Lorna Dove, MD, MPH | Chair,
Bernd Schnabl, MD, FAASLD | Chair,
Michael R Lucey, MD, FAASLD | Chair,
Hanna Blaney, MD, MPH | Moderator,
Rotonya Carr, MD, FACP, FAASLD | Moderator,
Brian P Lee, MD MAS | Presenter,
Meena B Bansal, MD, FAASLD | Presenter,
Stephanie Rutledge, MD, MB BCh, BAO, MRCPI | Presenter,
John P Rice, MD | Presenter,
Patrick Northup, MD, FAASLD | Moderator,
Anahita Rabiee, MD | Moderator,
Guadalupe Garcia-Tsao, MD, FAASLD | Presenter,
Robert S. Brown, MD, MPH, FAASLD | Presenter,
Virginia Hernandez-Gea, MD, , MD, PhD | Presenter,
Patrick S. Kamath | Presenter,
Norah Terrault, MD, MPH, FAASLD | Moderator,
Scott Biggins, MD, MAS, FAASLD | Moderator,
Cynthia Levy, MD, FAASLD | Presenter,
Heiner Wedemeyer, MD | Presenter,
Giuseppe Cullaro, MD | Presenter,
Anjana Pillai, MD, FAASLD | Presenter,
Gregory Gores, MD | Moderator,
Veeral Ajmera | Moderator,
Mia Lozada, MD | Presenter,
Ashley Spann, MD, MS | Presenter,
Vincent WS Wong, MD | Presenter,
Kim M Olthoff, MD | Presenter
Course
9:45 AM - 6:45 AM
Convention Center - Bluebird Ballroom 1C

Academic Debate: Is Resmetirom or Semaglutide the Best First-Line Treatment for Metabolic Dysfunction–Associated Steatohepatitis With Stage 2–3 Fibrosis?

Heather Patton, MD, FAASLD | Panelist,
Meena B Bansal, MD, FAASLD | Panelist,
Vincent Chen | Panelist,
Mazen Noureddin, MD, MHSc | Panelist,
Alexander Kuo, MD, FAASLD | Chair,
Brent A Neuschwander-Tetri, MD, FAASLD | Moderator,
Alexander N Scherer, MD, PhD | Chair,
Marlyn J. Mayo | Chair
Academic Debates
2:00 PM - 11:30 AM
Convention Center - Bluebird Ballroom 3DEF
Recorded session

More Than Fibrosis: The Biology and Prognostic Power of Liver Stiffness, Part 2

Yasuko Iwakiri, PhD, FAASLD | Presenter,
Nidhi Jalan-Sakrikar, PhD | Presenter,
Maria Carlota Londono, MD | Presenter,
Meena B Bansal, MD, FAASLD | Moderator,
Craig S Lammert, MD, MS, | Chair
Lecture
9:45 AM - 6:45 AM
Convention Center - Bluebird Ballroom 2GH

Screening for Liver Fibrosis in Metabolic Dysfunction–Associated Steatotic Liver Disease: A Population Health Perspective

Sujit Janardhan, MD, PhD, Dipl ABOM | Presenter,
Rena K Fox, MD | Presenter,
Meagan E Gray, MD | Presenter,
Meena B Bansal, MD, FAASLD | Moderator,
Saroja Bangaru, MD | Moderator,
Meena B Bansal, MD, FAASLD | Chair
Community Conversations
8:00 AM - 5:30 AM
Convention Center - Bluebird Ballroom 2DEF
Recorded session

General Hepatology Update: Contemporary Management of Advanced Liver Diseases—From Metabolic Dysfunction–Associated Steatohepatitis Therapies to Decompensated Cirrhosis

Sudha Kodali, MD, MSPH | Presenter,
Meena B Bansal, MD, FAASLD | Presenter,
Jennifer C Lai, MD, MBA | Presenter,
Jessica Bartholomew, MSN, FNP-C | Moderator,
Anthony Derencius, MPAS, PA-C | Moderator,
Anthony Derencius, MPAS, PA-C | Chair,
Sudha Kodali, MD, MSPH | Chair
Lecture